Teresa Kleintop

Papers

Total Citations

137

H-Index

About

Teresa Kleintop is a distinguished pharmaceutical scientist whose work has significantly advanced drug discovery and development, particularly in the realm of preclinical screening. Her research centers on optimizing high-throughput assays to evaluate drug metabolism and pharmacokinetics, with a focus on microsomal stability—a critical parameter for predicting a compound’s metabolic fate. Kleintop’s most impactful contribution, the 2003 paper "Optimization of a Higher Throughput Microsomal Stability Screening Assay for Profiling Drug Discovery Candidates," has garnered 137 citations, underscoring its influence in streamlining early-stage candidate profiling. This work introduced a robust, efficient method for assessing metabolic stability, enabling researchers to rapidly identify promising leads and reduce attrition rates in later development stages. By enhancing assay throughput without compromising data quality, Kleintop’s innovations have become a cornerstone in medicinal chemistry and ADME (absorption, distribution, metabolism, excretion) studies. Her achievements reflect a commitment to bridging the gap between laboratory efficiency and clinical relevance, making her a key figure in improving the success rates of drug discovery pipelines. For students and researchers, Kleintop’s contributions exemplify how methodical optimization can accelerate the journey from bench to bedside.